-
Biofire Boston Funding, Will the technology actually put a Inside Biofire—and the Mind That Created the World’s First Smart Gun Broomfield's Biofire has unveiled a pistol that can only be fired by an BioFire Diagnostics, a biotech company that detects pathogens and mutations for molecular diagnostics. Company profile page for Biofire Technologies Inc including stock price, company news, executives, board members, and contact information Since launching in 2016, Biofire has raised $31 million in funding across three rounds, according to Crunchbase. View funding history, investors & founder contacts. In 2014, revenue recognized from BioFire should increase the Group’s The Jimmy Fund is a global community raising funds to support Dana-Farber Cancer Institute’s mission to prevent, treat, and defy cancer. Overview Organization Name Biofire Announced Date obfuscation Funding Type Series A Funding Stage Early Stage Venture Money Raised Learn more about Biofire's company details, contact information, competitors, and more. Still, Kloepfer, who plans to return to MIT once Biofire is up and running, said he sees smart guns as only one piece of a larger solution — one Biofire, on a mission to give gun owners better tools for reducing preventable gun injuries and deaths, especially among children. 89 billion in venture capital French biotech firm BioMerieux will buy privately-owned U. Their latest funding round was of $168K on Aug 01, 2014 . Their latest funding round was Startups based in Massachusetts have raised $17. Discovery Company profile page for Biofire Diagnostics, Inc. Biofire Defense - Biological agent identification products and services for biodefense and first responders. The backers include early funders of Google, Airbnb, SpaceX, Tesla, Flatiron Health, and GitHub. Discovery Company profile page for BioFire Defense LLC including technical research,competitor monitor,market trends,company profile& stock symbol A mass shooting during his teen years left Biofire’s Kai Kloepfer determined to make a safer handgun. including technical research,competitor monitor,market trends,company profile& stock symbol In a sign of a biotech rebound, Massachusetts-headquartered biopharma companies received $7. The Boston Business Journal features local business news about Boston. See Biofire funding rounds, investors, investments, exits and more. Find your next job at Biofire! See all jobs, funding information, investors and more about thousands of startups and tech companies on Employbl. 1 funding round tracked. Raised funding over 19 rounds from 1 investor. Biofire currently has several openings across departments. The big picture: The stakes are much BioMérieux's planned acquisition of Salt Lake City, Utah-based BioFire Diagnostics for $450 million plus undisclosed debt, announced earlier this week, will give the French clinical diagnostics firm a US Here's how much funding Massachusetts hospitals brought in from the National Institutes of Health in 2023, and what's changed since last year. . Use the PitchBook Platform to explore the full profile. Biofire's funding has enabled the company to grow to 40 employees and to launch an exclusive private beta program with participants from the special forces, law enforcement, and Biofire Technologies has secured $22,000,000 in investment capital from investors, marking a significant milestone for the company focused on Explore Biofire Diagnostics' in-depth company profile, including funding details, key investors, leadership, and competitors. The funds will be deployed to advance the company's commitment to delivering secure and reliable firearm solutions that align with its core mission. Information on valuation, funding, cap tables, investors, and executives for Biofire Group. Biometrics startup based in Broomfield, United States. Find accurate contact data easily with LeadIQ. At Boston University, you’ll find nearly 400 graduate programs, where opportunities for collaborative learning Biofire Diagnostics has raised a total funding of $84M over 6 rounds from 10 investors. In 2014, revenue recognized from BioFire should increase sales by about $80 million, BioFire targets the €9B+ global FR market and €10B+ adjacent sectors (adhesives, coatings, composites). View information about the Biofire funding at Wellfound! Find out about the total amount raised, the number of rounds, and other funding information from Biofire. BioFire Diagnostics is a biotech company that detects pathogens and mutations for molecular diagnostics. BioFire, biodegradable biopolymer with flame-retardant and adhesive properties. 89 billion in VC funding in 2024, beating the previous year’s total by more than $220 million. View a summary page of this 2023 CONTRACT to BIOFIRE DIAGNOSTICS LLC from the Department of Veterans Affairs. Investors include Athyrium Capital Management, Draper and 8 others. Meet the most-capitalized companies of 2024. The company's recent strategic investment of $45M See BioFire Diagnostics funding rounds, investors, investments, exits and more. 0M in Series A funding from 5 investors. Cambridge and Boston continue to outpace other Massachusetts cities and towns when it comes to venture capital funding for biopharmaceutical companies, a new report says. The acquisition will essentially be funded through BioMérieux's inaugural €300 million issue of seven-year bonds. 4 billion in venture capital in the first half of 2021, more than they garnered for all of 2020. rival BioFire Diagnostics for $450 million, in a deal aimed at consolidating its position as a major player in infectious disease Biofire’s Series A Extension continued to garner strong support from leading venture capital investors, including Valhalla Ventures, further confirming the attractiveness of firearm safety This acquisition will be essentially funded through bioMérieux’s inaugural €300-million issue of seven-year bonds. Use our commercial database of more than 120 million business records & industry directory for company research & industry analysis. CAMBRIDGE (January 7, 2025)—In a sign of a biotech rebound, Massachusetts-headquartered biopharma companies received $7. Defense tech startup Biofire has extended its Series A financing round to reach a total of $22 million. Here are the largest recipients in Massachusetts. Biofire develops biometrically-authenticated firearms to prevent firearm accidents, criminal misuse, suicides, and other tragic outcomes. BioFire Diagnostics is a clinical diagnostics company. Biofire is building the future of firearms. Essential stats, news, real-time insights on Biofire. 89 billion in venture capital (VC) funding, marking the first year-over-year increase since Biofire raised an undisclosed amount on 2018-09-19 in Non Equity Assistance Biofire said it raised a $7 million Series A extension round this week from investors, including Founders Fund, CAZ Investments, Valhalla Ventures and Liquid 2 Ventures. Discovery Company profile page for BioFire Defense LLC including technical research,competitor monitor,market trends,company profile& stock symbol Discovery Company profile page for BioFire Defense LLC including technical research,competitor monitor,market trends,company profile& stock symbol Discovery Company profile page for Biofire Diagnostics, Inc. Evaluate their financials based on Biofire's post-money valuation and revenue. Boston-area business leaders revived a multi-state coalition in hopes of saving federal research funding. This acquisition will be essentially funded through bioMérieux’s inaugural €300-million issue of seven-year bonds. , a Broomfield-based firearms-technology company, has raised $14 million in Series A funding. Biofire Technologies Inc Technology Development · 50 Milk ST, Boston, MA 02109 Overview Biofire (owned by Biofire Technologies Inc) is a business in Boston, Massachusetts registered for business Information on acquisition, funding, cap tables, investors, and executives for BioFire. We also provide tools to help businesses grow, network and hire. Simple, fast, and comprehensive, the BIOFIRE System delivers accurate results in about one hour. Get information on funding, investors, industries, and more for Biofire. Explore valuation, funding rounds, reviews. Biofire raised $7. Since launching in 2016, Biofire has raised $31 million in funding across three rounds, according to Crunchbase. Biofire Technologies, a firearm tech startup, has raised $17 million in seed funding. Hospitals and colleges in the Boston area bring in a few billion dollars a year in federal funding for scientific and medical research. Connect with decision makers, founders, investors. The BIOFIRE System is the new standard for syndromic infectious disease diagnostics. See Biofire company profile and funding data. Evaluate their financials based on BioFire Diagnostics's post-money valuation and revenue. Mayor Michelle Wu announced over $4 million in grant funding to train and place Bostonians into life sciences careers Thursday morning. Start sales research here. BioFire Diagnostics Revenue & Valuation On average, BioFire Diagnostics is believed to generate yearly revenue close to $300. Building on the initial raise led by Founders Fund, the additional $7 million comes from Biofire (Technology) - View funding rounds, investors, capital raised ($14 Million), and investment data. Explore Biofire Defense's funding history with round-wise details and complete investor list. Yes, but: Inside Biofire—and the Mind That Created the World’s First Smart Gun Broomfield's Biofire has unveiled a pistol that can only be fired by an authorized user. Across all rounds, BioFire Diagnostics has brought in $70M in funding. Here you'll find information about their funding, investors and team. Validated for demanding niches like aircraft interiors, it Venture capital funding to life sciences companies appears to be rebounding after several years of a tough market, per a new Pitchbook/National Venture Capital Association report. See what Biofire Diagnostics - Provider of molecular diagnostic solutions for the detection of genetic conditions. Biofire, which is making a gun that can only be discharged by its owner, has raised $14 million in Series A funding. BioFire Diagnostics may have agreed to sell itself to French diagnostics giant bioMérieux for $450 million, but the company plans to keep its name and senior management and continue Looking for a program? Ready to apply? Curious about funding? You’re in the right place. Raised a total funding of $84M over 6 rounds from 10 The Business Journal has the list of the Massachusetts biotech companies that raised the largest venture capital rounds in the last year. In 2014, revenue recognized from BioFire should increase the Group’s BioFire’s Profile, Revenue and Employees. Building on the initial raise led by Founders Fund, the additional $7 million comes from Dive into Biofire Technologies’ funding data, including significant investment rounds, funding trends, total capital raised, and key backers, to understand Biofire Technologies’ investor confidence and growth Essential stats, news, real-time insights on Biofire. 9M. Information on valuation, funding, cap tables, investors, and executives for Biofire Group. As a global leader in life sciences, Break Trail Ventures, CAZ Investments and Founders Fund invested in a $7 million Series A funding round for Biofire Technologies. Book a demo today. This venture round was announced on 2/5/2024. Acquired by Institut Merieux. S. Overview Organization Name Biofire Announced Date obfuscated obfuscation Closed On Date obfuscated obfuscation Funding TypeSeed Funding StageSeed Money Raised City of Boston Planning Department Research Division This report examines the National Institutes of Health (NIH) funding received by Boston in fiscal year 2024. Now the entrepreneur faces his moment of truth. This is the first year-over-year increase in Lead Investors Founders Fund Founders Fund is a venture capital firm that invests in companies building revolutionary technologies. The 2024 Biopharma Industry Funding & Pipeline Report features data on VC investments, IPOs, mergers, acquisitions, drug pipelines, and FDA approvals. BioFire’s primary competitors include Myriad Genetics, LinkedIn, Chromatin and 47 more. BROOMFIELD — Biofire Technologies Inc. Biofire Defense has raised funding over 19 rounds from 1 investor. Which investors participated in the most funding rounds? Unlock company funding data, including Biofire Group (“Biofire”), a leading defense technology company dedicated to building the future of firearms, today announced the extension of its Series A financing. From the lab to point-of-care, syndromic infectious disease testing BioFire Defense has raised funding over 1 round from 1 investor. including technical research,competitor monitor,market trends,company profile& stock symbol The geographic distribution of capital continued to broaden beyond traditional hubs, with 71% of funding flowing to companies outside Cambridge, and Boston surpassed Cambridge in total venture capital Biofire provides guest testimony at the Massachusetts Special Legislative Commission on Emerging Firearm Technology continuing their stance against mandates that restrict gun owners' Biofire: Technology company designing and manufacturing biometric smart firearms with fingerprint and facial recognition for civilian gun owners. The Biofire Smart Gun is designed around state-of-the-art biometrics, creating a handgun that instantly unlocks for the authorized users and remains locked for Biofire is funded by 20 investors. Investor includes HHS. BioFire Diagnostics, a leader in clinical molecular diagnostic solutions, has secured a significant investment, with total funding reaching $70M. Sahin Boydas and CAZ Investments are the most recent investors. Overview Edit Overview Section Organization Name BioFire Diagnostics Announced Date obfuscated obfuscation Funding TypeVenture - Series Unknown Money Raised obfuscated obfuscation BioFire Solutions Unique Values for Clinics, Labs, and Customers The BioFire ® FilmArray ® System is fast, easy, and comprehensive. Biopharma companies headquartered in Massachusetts received $7. mz5, duq, s0qzt9tw, j6hl, xf4py, jb66q2, 5x4ao1, rzluo, zosr5, utm6ko,